ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,838, issued on July 14, was assigned to Shanghai Zheye Biotechnology Co. Ltd. (Shanghai).
"Aromatic compound and application thereof in antitumor drug" was invented by Qiang Zhang (Shanghai), Fengtian Du (Shanghai), Haibo Wang (Shanghai), Na Guo (Shanghai) and Tao Zhang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "An aromatic compound protein inhibitor, a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, a method related to the preparation and use of the compound, a pharmaceutical composition comprising the compound, and a relevant cancer treatment method. The aromatic compound has selective and significant inhibit...